Duralast
Duralast Price range: $ 54,00 through $ 140,00
Back to products
Duricef
Duricef Price range: $ 45,00 through $ 205,00

Duratia

Price range: $ 43,00 through $ 526,00

Duratia is an effective pharmaceutical solution specifically designed to address the challenges of premature ejaculation in adult men. The active ingredient, Dapoxetine, works by increasing serotonin activity in the nervous system to help delay the climax response during physical intimacy. By significantly extending the duration of sexual encounters, this medication helps users achieve much greater control over the timing of ejaculation. Many men report enhanced sexual satisfaction and a significant reduction in distress related to performance timing after using this treatment. This reliable formula is widely recognized for its ability to improve overall sexual confidence and promote a more fulfilling experience for both partners.

Active substance: Dapoxetine
SKU: Duratia Category:
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM

Each dosage option has its own packaging choices.

Description

Duratia belongs to a group of pharmacological agents known as short-acting selective serotonin reuptake inhibitors (SSRIs), engineered specifically to target neurochemical pathways involved in ejaculatory control. Containing the active ingredient dapoxetine, it is designed for rapid systemic absorption and swift elimination from the human body. Any access to or use of this medication must be dispensed in accordance with applicable federal and state regulations.

Evaluating Duratia requires a balanced understanding of its pharmacological mechanisms, clinical utility, and safety considerations. On one hand, its unique kinetic profile allows for on-demand dosing rather than continuous daily administration; on the other hand, proper medical supervision remains essential to minimize risks associated with serotonergic activity and potential cardiovascular side effects.

Core Medical Information

Basic Information

Parameter Details
Drug Name Duratia
Active Ingredient (INN) Dapoxetine
Therapeutic Class Short-acting Selective Serotonin Reuptake Inhibitor (SSRI)
Dosage Form Oral tablet
Route of Administration Oral
Primary Purpose Treatment of premature ejaculation in adult men
Prescription Status Dispensed in accordance with applicable federal and state regulations

How the drug works

Duratia exerts its physiological action primarily by inhibiting the neuronal reuptake of serotonin (5-hydroxytryptamine or 5-HT) and subsequently enhancing the neurotransmitter’s activity within the central nervous system. The ejaculation reflex is orchestrated predominantly by the sympathetic nervous system. Serotonergic pathways within specific brain structures, including the lateral paragigantocellular nucleus, play a central role in modulating this reflex. By increasing serotonin levels at the synaptic cleft, dapoxetine enhances the threshold for ejaculatory triggering, thereby prolonging the intravaginal ejaculatory latency time (IELT). Unlike classical SSRIs utilized for mood disorders, Duratia exhibits rapid binding kinetics and a swift dissociation profile, which prevents long-term accumulation while delivering targeted neurological modulation.

Main uses

Duratia is indicated for the management of premature ejaculation (PE) in adult men aged 18 to 64 years who present with persistent or recurrent ejaculation with minimal sexual stimulation before, upon, or shortly after penetration. On one hand, clinical evaluations demonstrate its efficacy in extending latency times and improving patient-reported control over ejaculation. On the other hand, it is not indicated for general erectile dysfunction, low libido, or non-ejaculatory sexual disorders. Healthcare providers evaluate whether a patient meets the clinical criteria for PE prior to initiating therapy, ensuring that underlying psychological or organic causes are appropriately addressed.

Dosing schedule

The standard initial recommended dose of Duratia is 30 mg, taken as needed approximately 1 to 3 hours prior to anticipated sexual activity. If the clinical response is insufficient and the patient has not experienced moderate or severe adverse reactions or prodromal symptoms suggestive of syncope, the dose may be titrated up to a maximum limit of 60 mg. The tablet should be swallowed whole with a full glass of water to reduce the risk of lightheadedness or syncope. Duratia is not intended for continuous daily administration and should not be taken more frequently than once every 24 hours. Dosage adjustments must be supervised by a physician, particularly in individuals with mild hepatic or renal impairment.

Pharmacokinetic and Clinical Profile

What happens in the body

Following oral administration, dapoxetine is rapidly absorbed, reaching peak plasma concentrations within approximately 1 to 2 hours. Its absolute bioavailability is approximately 42%. Protein binding is high, exceeding 99% for the active drug and its primary metabolites. Dapoxetine undergoes extensive hepatic metabolism via cytochrome P450 enzymes, predominantly CYP2D6 and CYP3A4, yielding active metabolites such as desmethyldapoxetine, though the parent compound accounts for the vast majority of pharmacological activity. The initial elimination half-life is short, ranging between 1.3 and 1.5 hours, while the terminal half-life is approximately 19 hours. This rapid clearance profile minimizes tissue accumulation and limits prolonged systemic exposure compared to traditional serotonergic agents.

What to expect when starting treatment

During the initial doses of Duratia, patients may observe mild physiological shifts as the central nervous system adapts to elevated synaptic serotonin levels. Mild nausea or transient lightheadedness within the first few hours of ingestion is not uncommon. It is advisable to remain sitting or lying down if feeling faint after taking a dose. Patients should evaluate their individual physiological response prior to operating heavy machinery or driving a motor vehicle. Consistent communication with a healthcare professional during the initial treatment phase helps determine whether dosage adjustment or discontinuation is appropriate.

Signs of improvement

Evaluating the therapeutic effect of Duratia involves monitoring changes in ejaculatory control and latency duration during intimate encounters. Successful response is characterized by an extended duration prior to ejaculation, improved control over the ejaculatory reflex, and reduced psychological distress regarding performance. Peak therapeutic activity typically occurs 1 to 3 hours after administration. If no perceptible increase in control or latency is achieved after several trial doses, or if adverse effects outweigh benefits, consultation with a qualified medical provider is necessary to reassess the treatment strategy.

Safety, Interactions, and Considerations

Compatibility with other medicines

Duratia presents significant potential for pharmacokinetic and pharmacodynamic interactions. Co-administration with potent CYP3A4 inhibitors (such as ketoconazole, ritonavir, or itraconazole) significantly increases dapoxetine exposure and is contraindicated. Concomitant use with monoamine oxidase inhibitors (MAOIs), thioridazine, or other serotonergic medications (including selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, and herbal remedies like St. John’s wort) carries a risk of serotonin syndrome; a 14-day washout period is required between stopping MAOIs and starting Duratia. Additionally, combining Duratia with alpha-blockers or antihypertensive agents may amplify orthostatic vasodilation, increasing the likelihood of syncope or severe postural hypotension.

What side effects may occur

While many individuals tolerate Duratia adequately, adverse reactions are frequently reported during clinical assessment. Common side effects include nausea, dizziness, headache, insomnia, somnolence, diarrhea, and fatigue. On one hand, gastrointestinal symptoms like nausea are often transient and mild to moderate in severity. On the other hand, central nervous system effects such as dizziness and lightheadedness require careful observation. Syncope, characterized by sudden loss of consciousness, has been observed in clinical trials and is frequently preceded by prodromal symptoms such as bradycardia, sweating, or lightheadedness. Patients experiencing severe mood alterations, confusion, or visual disturbances should discontinue the medication and notify their prescribing provider immediately.

Important Precautions and Avoidance

Important precautions

Caution is warranted when administering Duratia to vulnerable patient populations. The medication is contraindicated in individuals with moderate to severe hepatic impairment, severe renal impairment, or pre-existing cardiac conditions such as heart failure, conduction abnormalities, or significant ischemic heart disease. Duratia is not indicated for use in women, children, or adolescents under 18 years of age. Elderly patients (65 years and older) have limited clinical data, requiring careful evaluation before initiating therapy. Orthostatic hypotension evaluations should be conducted prior to treatment initiation. Patients with a history of mania, severe depression, or bipolar disorder must be monitored, as serotonergic agents can exacerbate underlying mood disturbances.

What to avoid while taking it

Combining Duratia with ethanol (alcohol) increases the risk of neurocardiogenic adverse events, including syncope, and heightens central nervous system depression. Patients are advised to completely avoid alcohol consumption while taking this medication. Duratia may be taken with or without food; however, consuming high-fat meals does not clinically alter the absorption profile of dapoxetine to a meaningful degree. Grapefruit juice and products containing grapefruit should be avoided, as grapefruit acts as a moderate inhibitor of CYP3A4 enzymes, potentially increasing active plasma concentrations and toxicity risks.

Practical tips

To ensure safe usage, Duratia should always be ingested with a complete glass of water (at least 8 ounces) to help mitigate potential blood pressure drops and syncope. Keep track of dosage timing in relation to planned sexual activity, remembering that it is an on-demand medication rather than a daily routine drug. Store tablets in their original packaging at room temperature, away from excessive moisture and direct sunlight. Avoid splitting or crushing tablets, as the medication is formulated for intact oral ingestion.

Frequently Asked Questions

Can Duratia be taken on an empty stomach or with meals?

Duratia can be ingested either with or without food, as systemic absorption is not significantly delayed by standard meal intake. However, taking the tablet with a light meal or a full glass of water may help diminish potential gastrointestinal side effects such as mild nausea.

What should happen if syncope or dizziness occurs after taking this medication?

If prodromal symptoms like lightheadedness, sweating, or dizziness develop, you should immediately lie down with your legs elevated or sit down with your head between your knees until symptoms resolve. Avoid rising rapidly. You must inform your physician before taking any subsequent doses.

Why is Duratia classified differently from daily antidepressant SSRIs?

While sharing a similar biochemical mechanism with classic SSRIs, Duratia (dapoxetine) is engineered with a distinct pharmacokinetic profile featuring rapid absorption and rapid systemic elimination. This allows for on-demand dosing prior to sexual activity, whereas antidepressant SSRIs require daily administration over weeks to achieve therapeutic steady-state levels.

How does alcohol consumption affect the safety profile of Duratia?

Alcohol acts synergistically with dapoxetine to impair central nervous control and increase vasodilation. Combining the two significantly elevates the risk of severe dizziness, somnolence, slow reflex response, and syncopal episodes. Therefore, alcohol consumption should be strictly avoided on days when Duratia is used.

Is Duratia intended for continuous daily administration?

No, Duratia is specifically formulated for PRN (as-needed) use prior to anticipated sexual intercourse. Continuous daily administration has not been established as safe or necessary for this agent, and taking it more than once within a 24-hour period increases the risk of systemic toxicity and adverse cardiovascular reactions.

In accordance with FDA requirements, patients should note that dapoxetine is evaluated under specific regulatory frameworks and may not be approved for all indications in all jurisdictions.

This text is for informational purposes only and does not constitute individual medical advice.

Additional information
Dosage

30mg

,

60mg

,

90mg

Package

10 pills

,

20 pills

,

30 pills

,

60 pills

,

90 pills

,

120 pills

,

180 pills

,

270 pills

,

360 pills

Ενεργός Ουσία